UPDATE: NEW EVIDENCE FROM HIGH-RISK OPIOID USE AND INFECTIOUS DISEASE INCIDENCE – OPIOID SUBSTITUTION TREATMENT (OST) IS WORSENING, NOT TREATING AMERICA’S LETHAL EPIDEMICS – PHILADELPHIA
by Clark Miller
Published August 29 , 2019
Updated April 14, 2021
The opioid crisis is worsening.
Hepatitis A and other infectious drug injection-related diseases are on the rise in the U.S. “in wake of opioid crisis”, caused by unrelenting, continuing increases in high-risk opioid use. And the more gold standard medical cure applied to diseased brains, the more high-risk use and deaths mount.
Philadelphia is experiencing the same trend.
“Rosario’s story is an increasingly common one in Philadelphia. Infections stemming from intravenous drug use are on the rise here — from the kinds of bacterial infections that Rosario suffered, to endocarditis. This infection of the the inner lining of the heart chambers and valves occurs when bacteria in the blood attach to the heart. Viruses like HIV, hepatitis C, and hepatitis A are also on the rise among people who use drugs.”
Significant, extended increases in medical provision of buprenorphine and methadone OST
should necessarily have resulted in the opposite outcome – decreases over the same time period of high-risk opioid use and associated decrease in risk and incidence of injection-related infectious disease.
Unless, as is generally and predictably the case, the provision of a medical model “treatment”, unsupported and indicated against by research evidence for an entirely non-medical condition – compulsive problem opioid use – has predictably resulted in a worsening of an iatrogenic lethal opioid crisis rather than providing benefit.
These consistently accumulating results – high-risk opioid use increasing in response to increasing provision of the medical model “treatment” for high-risk opioid use – predictably invalidate and expose the fabricated evidence base for the publicly-funded medical fix for the non-medical condition of compulsive substance use.
For rates of opioid injection-related infectious disease, as with increasing rates of another measure of high-risk opioid use , non-lethal overdose – as provision of the medical cure increases, predictable, invalidating outcomes and patterns are emerging.